Advanced Rectal Cancer Current Events | Advanced Rectal Cancer News | 7
|
| Page
7 of
105 |
2089 Results |
|
|
|
Sort By:
Page Views | Date |
Combination therapy shows promising results in patients with advanced lung cancer
An early phase study pairing an experimental targeted therapy with a common anti-inflammatory produced promising results in patients with advanced lung cancer, researchers at UCLA's Jonsson Cancer Center reported. view more (2006-06-01)
Drug used for advanced cancer could cause exposed bone in jaw
A type of drug used to strengthen bones when cancer has spread there may be linked to a side effect that involves deterioration of the jaw bone, according to two new reviews of cancer literature. view more (2006-10-03)
Study shows that administering calcium and magnesium effectively reduces neurological sensitivity
Researchers in the North Central Cancer Treatment Group (NCCTG) have shown that patients who receive intravenous calcium and magnesium before and after the chemotherapy drug oxaliplatin for the treatment of advanced colon cancer experience a significantly reduced incidence and severity of neurological side effects (neurotoxicity). view more (2008-05-16)
Anti-tumor effects are enhanced by inhibiting 2 pathways rather than 1
Two independent research groups have found that simultaneous inhibition of two signaling pathways resulted in substantially enhanced antitumor effects in mouse models of prostate and breast cancer. In an accompany commentary, Steven Grant, at Virginia Commonwealth University Health Science Center, Richmond, discusses the clinical importance of... view more... (2008-08-22)
Exercise reduces fatigue in cancer patients undergoing chemotherapy
Supervised exercise programmes that include high and low intense cardiovascular and resistance training can help reduce fatigue in patients with cancer who are undergoing adjuvant chemotherapy or treatment for advanced disease. view more (2009-10-14)
Study finds cardiac toxicity rates high with herceptin use
The first study to look at "real world" use of Herceptin in advanced breast cancer patients found a higher incidence of cardiac toxicity - 28 percent of patients treated - than clinical trials of the drug have reported to date, but also concluded that the majority of this heart damage could be reversed with treatment. view more (2006-08-15)
Whites take supplemental breast cancer therapy more often than blacks
A new study finds that white women more frequently take more of the life-prolonging supplemental therapies used to treat breast cancer than African-American women. view more (2007-10-08)
'Clumping' protein linked to return of ovarian cancer
Johns Hopkins scientists have discovered that women treated for ovarian cancer are at increased risk of a rapid and potentially fatal recurrence if their tumor cells have high levels of a binding protein that triggers abnormal growth and slows down cell death, both hallmarks of malignancy. view more (2006-12-18)
Selenium may prevent high risk-bladder cancer
A study published in the December issue of Cancer Prevention Research, a journal of the American Association for Cancer Research, suggests that selenium, a trace mineral found in grains, nuts and meats, may aid in the prevention of high-risk bladder cancer. view more (2008-12-08)
Early detection of lung cancer: New data presented at multidisciplinary meeting
New data from several studies evaluating new techniques for early diagnosis and treatment of lung cancer are being presented at the first European Multidisciplinary Conference on Thoracic Oncology (EMCTO) in Lugano, Switzerland (1-3 May 2009). view more (2009-05-04)
Study implicates protein as a trigger of advanced prostate cancer recurrence
Scientists with the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have for the first time implicated a growth-promoting cellular protein as one trigger of the inevitable recurrence of advanced prostate cancer in men who are undergoing drug treatment to shut down their sex hormones, or androgens. view more (2007-05-09)
European trial finds old lung cancer treatment may still be best
The first clinical trial to compare directly two of the most widely-used drugs in advanced lung cancer, cisplatinin and carboplatin (both in combination with paclitaxel) - have concluded that the older drug, cisplatin, is the better treatment. Patients given cisplatin and paclitaxel had better survival rates and their quality of life was just as... view more... (2002-10-07)
Prevalence of pre-cancerous masses in the colon same in patients in their 40s and 50s
The prevalence of pre-cancerous masses in the colon is the same for average-risk patients who are 40 to 49 years of age and those who are 50 to 59 years of age. view more (2008-06-11)
Hormone drug type makes survival difference in advanced breast cancer
Aromatase inhibitors, a type of hormone therapy used to treat advanced breast cancer in postmenopausal women, result in a small but significant increase in overall survival when compared to other hormone treatments, according to a new systematic review of studies. view more (2007-01-31)
Knee arthritis link to lung cancer
Arthritis of the knee may be the first sign of a type of lung cancer that is hard to treat in heavy smokers, suggests research published ahead of print in the Annals of the Rheumatic Diseases. view more (2007-09-04)
Cancer patients, spouses report similar emotional distress, U-M study finds
A cancer diagnosis affects more than just the patient. A new study from researchers at the University of Michigan Comprehensive Cancer Center finds spouses report similar physical and emotional quality of life as the patient. view more (2007-09-21)
Sometimes no treatment is the right option for low-risk prostate cancer
When Houston restaurateur Tony Masraff was diagnosed with early-stage prostate cancer, his life was packed with dancing, running marathons, playing tennis, gardening, leading a successful business and spending time with his family. view more (2006-03-24)
Swiss study finds income affects prostate cancer patients' survival
Prostate cancer patients of low socioeconomic status are more likely to die than patients with higher incomes. view more (2009-09-28)
Doctors conclude temsirolimus is effective new treatment for advanced renal cell carcinoma
The results of a phase III, randomized clinical study involving patients with advanced renal cell carcinoma and poor prognostic features show temsirolimus improved overall survival when compared to the current treatment for this stage of disease. view more (2007-05-31)
Delaying Chemotherapy Could Be Best Treatment Option For Certain Type Of Non-hodgkin Lymphoma (p 516)
Delaying chemotherapy until symptoms develop for patients with asymptomatic advanced low-grade non-Hodgkin lymphoma is confirmed as an appropriate strategy authors of a UK study in this week's issue of THE LANCET. Chemotherapy (single or aggressive combination therapy) does not cure advanced stage low-grade non-Hodgkin lymphomas, even when... view more... (2003-08-13)
|
|
| Page
7 of
105 |
2089 Results |
|
|
|
Sort By:
Page Views | Date |
|
